Skip to content
10-Q

Quarterly Report

Nuvectis Pharma, Inc. NVCT

0001104659-25-105939

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 1, 2025 25.61M sh
Shares Diluted Q3 2025 · Sep 30, 2025 22.72M sh
Shares Diluted Q3 2025 · Sep 30, 2025 21.35M sh
Shares Diluted Q3 2025 · Sep 30, 2024 17.23M sh
Shares Diluted Q3 2025 · Sep 30, 2024 16.9M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$12.04M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$9.78M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $35.44M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $18.53M
Stockholders Equity Q3 2025 · Sep 30, 2025 $24.01M
Stockholders Equity Q3 2025 · Jun 30, 2025 $16.87M
Stockholders Equity Q3 2025 · Mar 31, 2025 $20.95M
Stockholders Equity Q3 2025 · Dec 31, 2024 $9.71M
Stockholders Equity Q3 2025 · Sep 30, 2024 $10.99M
Stockholders Equity Q3 2025 · Jun 30, 2024 $12.53M
Stockholders Equity Q3 2025 · Mar 31, 2024 $14.02M
Stockholders Equity Q3 2025 · Dec 31, 2023 $12.2M
Current Liabilities Q3 2025 · Sep 30, 2025 $11.58M
Current Liabilities Q3 2025 · Dec 31, 2024 $8.89M
Total Liabilities Q3 2025 · Sep 30, 2025 $11.58M
Total Liabilities Q3 2025 · Dec 31, 2024 $8.89M
Current Assets Q3 2025 · Sep 30, 2025 $35.59M
Current Assets Q3 2025 · Dec 31, 2024 $18.61M
Total Assets Q3 2025 · Sep 30, 2025 $35.59M
Total Assets Q3 2025 · Dec 31, 2024 $18.61M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.44
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.01
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.24
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.75
Eps Basic Q3 2025 · Sep 30, 2025 −$0.44
Eps Basic Q3 2025 · Sep 30, 2025 −$1.01
Eps Basic Q3 2025 · Sep 30, 2024 −$0.24
Eps Basic Q3 2025 · Sep 30, 2024 −$0.75
Sga Expense Q3 2025 · Sep 30, 2025 $2.02M
Sga Expense Q3 2025 · Sep 30, 2025 $6.89M
Sga Expense Q3 2025 · Sep 30, 2024 $1.54M
Sga Expense Q3 2025 · Sep 30, 2024 $4.98M
Rd Expense Q3 2025 · Sep 30, 2025 $5.77M
Rd Expense Q3 2025 · Sep 30, 2025 $13.07M
Rd Expense Q3 2025 · Sep 30, 2024 $2.82M
Rd Expense Q3 2025 · Sep 30, 2024 $8.42M
Net Income Q3 2025 · Sep 30, 2025 −$7.46M
Net Income Q3 2025 · Sep 30, 2025 −$19.13M
Net Income Q3 2025 · Jun 30, 2025 −$6.33M
Net Income Q3 2025 · Mar 31, 2025 −$5.33M
Net Income Q3 2025 · Sep 30, 2024 −$4.15M
Net Income Q3 2025 · Sep 30, 2024 −$12.75M
Net Income Q3 2025 · Jun 30, 2024 −$4.43M
Net Income Q3 2025 · Mar 31, 2024 −$4.17M
Operating Income Q3 2025 · Sep 30, 2025 −$7.79M
Operating Income Q3 2025 · Sep 30, 2025 −$19.96M
Operating Income Q3 2025 · Sep 30, 2024 −$4.36M
Operating Income Q3 2025 · Sep 30, 2024 −$13.4M